{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T21:40:10Z","timestamp":1742161210965,"version":"3.38.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,16]]},"DOI":"10.7759\/cureus.80673","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T21:00:26Z","timestamp":1742158826000},"source":"Crossref","is-referenced-by-count":0,"title":["Late-Onset Thyroid Hormone Resistance Following Total Thyroidectomy for Papillary Thyroid Cancer"],"prefix":"10.7759","author":[{"given":"Ambika","family":"Kapil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamella","family":"Morello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maray","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odalys","family":"Frontela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar S","family":"Abdelmoneim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-16-0003","article-title":"Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma","volume":"2016","author":"Igata M","year":"2016","unstructured":"Igata M, Tsuruzoe K, Kawashima J, et al.. Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma. Endocrinol Diabetes Metab Case Rep. 2016, 2016:160003. 10.1530\/EDM-16-0003","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1131044","article-title":"The clinical characteristics and gene mutations associated with thyroid hormone resistance syndrome coexisting with pituitary tumors","volume":"14","author":"Zhao J","year":"2023","unstructured":"Zhao J, Xu L, Li C, Wang F, Liao L, Dong J. The clinical characteristics and gene mutations associated with thyroid hormone resistance syndrome coexisting with pituitary tumors. Front Endocrinol (Lausanne). 2023, 14:1131044. 10.3389\/fendo.2023.1131044","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn Chair RS","year":"2011","unstructured":"Bahn Chair RS, Burch HB, Cooper DS, et al.. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011, 21:593-646. 10.1089\/thy.2010.0417","journal-title":"Thyroid"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911268","article-title":"Resistance to thyroid hormones: a case-series study","volume":"23","author":"Cannarella R","year":"2022","unstructured":"Cannarella R, Musmeci M, Garofalo V, et al.. Resistance to thyroid hormones: a case-series study. Int J Mol Sci. 2022, 23:11268. 10.3390\/ijms231911268","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/er.2006-0043","article-title":"The clinical significance of subclinical thyroid dysfunction","volume":"29","author":"Biondi B","year":"2008","unstructured":"Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008, 29:76-131. 10.1210\/er.2006-0043","journal-title":"Endocr Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-017-0046-z","article-title":"A clinician's guide to understanding resistance to thyroid hormone due to receptor mutations in the TR\u03b1 and TR\u03b2 isoforms","volume":"3","author":"Singh BK","year":"2017","unstructured":"Singh BK, Yen PM. A clinician's guide to understanding resistance to thyroid hormone due to receptor mutations in the TR\u03b1 and TR\u03b2 isoforms. Clin Diabetes Endocrinol. 2017, 3:8. 10.1186\/s40842-017-0046-z","journal-title":"Clin Diabetes Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2014.00010","article-title":"Differentiated thyroid cancer in patients with resistance to thyroid hormone syndrome. A novel case and a review of the literature","volume":"1","author":"Vinagre J","year":"2014","unstructured":"Vinagre J, Borges F, Costa A, Alvelos MI, Mazeto G, Sobrinho-Sim\u00f5es M, Soares P. Differentiated thyroid cancer in patients with resistance to thyroid hormone syndrome. A novel case and a review of the literature. Front Mol Biosci. 2014, 1:10. 10.3389\/fmolb.2014.00010","journal-title":"Front Mol Biosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4142","article-title":"Management of differentiated thyroid cancer in the presence of resistance to thyroid hormone and TSH-secreting adenomas: a report of four cases and review of the literature","volume":"98","author":"\u00dcnl\u00fct\u00fcrk U","year":"2013","unstructured":"\u00dcnl\u00fct\u00fcrk U, Sriphrapradang C, Erdo\u011fan MF, Emral R, G\u00fcldiken S, Refetoff S, G\u00fcll\u00fc S. Management of differentiated thyroid cancer in the presence of resistance to thyroid hormone and TSH-secreting adenomas: a report of four cases and review of the literature. J Clin Endocrinol Metab. 2013, 98:2210-7. 10.1210\/jc.2012-4142","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1014323","article-title":"Resistance to thyroid hormone beta coexisting with papillary thyroid carcinoma-two case reports of a thyroid hormone receptor beta gene mutation and a literature review","volume":"13","author":"Fang Y","year":"2022","unstructured":"Fang Y, Liu T, Hou H, Wang Z, Shan Z, Cao Y, Teng X. Resistance to thyroid hormone beta coexisting with papillary thyroid carcinoma-two case reports of a thyroid hormone receptor beta gene mutation and a literature review. Front Genet. 2022, 13:1014323. 10.3389\/fgene.2022.1014323","journal-title":"Front Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0233","article-title":"Differentiated thyroid cancer in two patients with resistance to thyroid hormone","volume":"21","author":"Paragliola RM","year":"2011","unstructured":"Paragliola RM, Lovicu RM, Locantore P, et al.. Differentiated thyroid cancer in two patients with resistance to thyroid hormone. Thyroid. 2011, 21:793-7. 10.1089\/thy.2010.0233","journal-title":"Thyroid"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2010.25.9.1368","article-title":"A case of resistance to thyroid hormone with thyroid cancer","volume":"25","author":"Kim HK","year":"2010","unstructured":"Kim HK, Kim D, Yoo EH, et al.. A case of resistance to thyroid hormone with thyroid cancer. J Korean Med Sci. 2010, 25:1368-71. 10.3346\/jkms.2010.25.9.1368","journal-title":"J Korean Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01033.x","article-title":"Toxic multinodular goitre in a patient with generalized resistance to thyroid hormone who harbours the R429Q mutation in the thyroid hormone receptor beta gene","volume":"54","author":"Taniyama M","year":"2001","unstructured":"Taniyama M, Ishikawa N, Momotani N, Ito K, Ban Y. Toxic multinodular goitre in a patient with generalized resistance to thyroid hormone who harbours the R429Q mutation in the thyroid hormone receptor beta gene. Clin Endocrinol (Oxf). 2001, 54:121-4. 10.1046\/j.1365-2265.2001.01033.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000091","article-title":"Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status","volume":"59","author":"Karakose M","year":"2015","unstructured":"Karakose M, Caliskan M, Arslan MS, Cakal E, Yesilyurt A, Delibasi T. Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status. Arch Endocrinol Metab. 2015, 59:364-6. 10.1590\/2359-3997000000091","journal-title":"Arch Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/345245-late-onset-thyroid-hormone-resistance-following-total-thyroidectomy-for-papillary-thyroid-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T21:00:27Z","timestamp":1742158827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/345245-late-onset-thyroid-hormone-resistance-following-total-thyroidectomy-for-papillary-thyroid-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,16]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.80673","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,16]]}}}